Search Results - "Wright, Kenneth L."
-
1
Histone deacetylase 8 inhibition suppresses mantle cell lymphoma viability while preserving natural killer cell function
Published in Biochemical and biophysical research communications (01-01-2021)“…Mantle Cell Lymphoma (MCL) is a non-Hodgkin lymphoma with a median survival rate of five years. Standard treatment with high-dose chemotherapy plus rituximab…”
Get full text
Journal Article -
2
The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance
Published in Nature immunology (01-01-2009)“…Interleukin 10 dampens inflammation and prevents excessive tissue damage during immune responses. Sotomayor and colleagues show that the histone deacetylase…”
Get full text
Journal Article -
3
Cellular differentiation regulator BLIMP1 induces Epstein-Barr virus lytic reactivation in epithelial and B cells by activating transcription from both the R and Z promoters
Published in Journal of virology (01-02-2015)“…Epstein-Barr virus (EBV) maintains a lifelong latent infection within a subset of its host's memory B cells, while lytic EBV replication takes place in plasma…”
Get full text
Journal Article -
4
HDAC11 deficiency disrupts oncogene-induced hematopoiesis in myeloproliferative neoplasms
Published in Blood (16-01-2020)“…Protein acetylation is an important contributor to cancer initiation. Histone deacetylase 6 (HDAC6) controls JAK2 translation and protein stability and has…”
Get full text
Journal Article -
5
Metabolic Vulnerabilities and Epigenetic Dysregulation in Myeloproliferative Neoplasms
Published in Frontiers in immunology (30-11-2020)“…The Janus kinase 2 (JAK2)-driven myeloproliferative neoplasms (MPNs) are associated with clonal myelopoiesis, elevated risk of death due to thrombotic…”
Get full text
Journal Article -
6
Oxidized Mitochondrial DNA Engages TLR9 to Activate the NLRP3 Inflammasome in Myelodysplastic Syndromes
Published in International journal of molecular sciences (15-02-2023)“…Myelodysplastic Syndromes (MDSs) are bone marrow (BM) failure malignancies characterized by constitutive innate immune activation, including NLRP3 inflammasome…”
Get full text
Journal Article -
7
Role of Stat3 in Regulating p53 Expression and Function
Published in Molecular and Cellular Biology (01-09-2005)“…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
8
Constitutively Activated DAP12 Induces Functional Anti-Tumor Activation and Maturation of Human Monocyte-Derived DC
Published in International journal of molecular sciences (27-01-2021)“…Dendritic cells (DCs) are professional antigen presenting cells with a great capacity for cross-presentation of exogenous antigens from which robust anti-tumor…”
Get full text
Journal Article -
9
PRDI-BF1 recruits the histone H3 methyltransferase G9a in transcriptional silencing
Published in Nature immunology (01-03-2004)“…PRDI-BF1, the human ortholog of mouse Blimp-1, is a DNA-binding protein involved in postinduction repression of interferon-beta gene transcription in response…”
Get full text
Journal Article -
10
Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis
Published in Oncogene (21-03-2002)“…Non-receptor and receptor tyrosine kinases, such as Src and EGF receptor (EGFR), are major inducers of vascular endothelial growth factor (VEGF), one of the…”
Get full text
Journal Article -
11
CX3CR1 deficiency-induced TIL tumor restriction as a novel addition for CAR-T design in solid malignancies
Published in iScience (21-04-2023)“…Advances in the understanding of the tumor microenvironment have led to development of immunotherapeutic strategies, such as chimeric antigen receptor T cells…”
Get full text
Journal Article -
12
Positive Regulatory Domain I (PRDM1) and IRF8/PU.1 Counter-regulate MHC Class II Transactivator (CIITA) Expression during Dendritic Cell Maturation
Published in The Journal of biological chemistry (11-03-2011)“…Dendritic cells (DCs) are key mediators of immune function through robust and tightly regulated presentation of antigen in the context of the MHC Class II. MHC…”
Get full text
Journal Article -
13
MDM2 recruitment of lysine methyltransferases regulates p53 transcriptional output
Published in The EMBO journal (04-08-2010)“…MDM2 is a key regulator of the p53 tumor suppressor acting primarily as an E3 ubiquitin ligase to promote its degradation. MDM2 also inhibits p53…”
Get full text
Journal Article -
14
Plasma cell dependence on histone/protein deacetylase 11 reveals a therapeutic target in multiple myeloma
Published in JCI insight (22-12-2021)“…The clinical utility of histone/protein deacetylase (HDAC) inhibitors in combinatorial regimens with proteasome inhibitors for patients with relapsed and…”
Get full text
Journal Article -
15
How Stat1 mediates constitutive gene expression: a complex of unphosphorylated Stat1 and IRF1 supports transcription of the LMP2 gene
Published in The EMBO journal (01-08-2000)“…Analysis of mRNA levels in cells that express or lack signal transducers and activators of transcription 1 (Stat1) reveals that Stat1 mediates the constitutive…”
Get full text
Journal Article -
16
PRDM1 is required for mantle cell lymphoma response to bortezomib
Published in Molecular cancer research (01-06-2010)“…Mantle cell lymphoma (MCL) is an aggressive form of B-cell lymphoma with a poor disease-free survival rate. The proteasome inhibitor bortezomib is approved for…”
Get full text
Journal Article -
17
Identification of a Functionally Impaired Positive Regulatory Domain I Binding Factor 1 Transcription Repressor in Myeloma Cell Lines
Published in The Journal of immunology (1950) (15-03-2003)“…B cell differentiation into a plasma cell requires expression of the positive regulatory domain zinc finger protein 1 gene (PRDM1) that encodes the positive…”
Get full text
Journal Article -
18
PU.1 Regulates Positive Regulatory Domain I-Binding Factor 1/Blimp-1 Transcription in Lymphoma Cells
Published in The Journal of immunology (1950) (01-11-2009)“…The human positive regulatory domain I-binding factor 1 (PRDI-BF1) and its murine homolog Blimp-1 promote differentiation of mature B cells into Ab-secreting…”
Get full text
Journal Article -
19
Coordinated silencing of MYC-mediated miR-29 by HDAC3 and EZH2 as a therapeutic target of histone modification in aggressive B-Cell lymphomas
Published in Cancer cell (16-10-2012)“…We investigated the transcriptional and epigenetic repression of miR-29 by MYC, HDAC3, and EZH2 in mantle cell lymphoma and other MYC-associated lymphomas. We…”
Get full text
Journal Article -
20
Immunodepletion of MDSC by AMV564, a novel bivalent, bispecific CD33/CD3 T cell engager, ex vivo in MDS and melanoma
Published in Molecular therapy (01-06-2022)“…We have reported previously that CD33hi myeloid-derived suppressor cells (MDSCs) play a direct role in the pathogenesis of myelodysplastic syndromes (MDSs) and…”
Get full text
Journal Article